Mountain States Tumor and Medical Research Institute

Mountain States Tumor and Medical Research Institute (MSTMRI) is the dedicated research arm of St. Luke's Cancer Institute, the largest oncology provider in Idaho and the surrounding region. Founded in 1969 and headquartered in Boise, the institute serves as a major hub for clinical oncology research in the Intermountain West, facilitating Phase 1 through Phase 4 clinical trials. MSTMRI provides patients with access to cutting-edge therapies, including novel immunotherapies and targeted agents, through extensive collaborations with National Cancer Institute (NCI) cooperative groups and global pharmaceutical partners. The organization is a key member of the NCI Community Oncology Research Program (NCORP), focusing on bringing advanced clinical research directly into the community healthcare setting. Its work spans a broad spectrum of malignancies, significantly contributing to the advancement of cancer treatment standards and patient outcomes.